Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Vizler

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damageN Bercovici, A Heurtier, C Vizler, et al.
British Journal of Cancer|March 31, 1999
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastasesL Quintieri, A Rosato, N Amboldi, et al.
European Journal of Immunology|November 1, 1993
Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in miceT Jánossy, L Baranyi, A C Knulst, et al.
Transplantation Proceedings|June 1, 1994
Long-term survival and use of human skin xenografts in immunosuppressed miceT Jánossy, C Vizler, J Krizsa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hostsC Vizler, N Bercovici, A Heurtier, et al.
Acta Chirurgica Hungarica|January 1, 1997
Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigensT Jánossy, C Vizler, I Ocsovszki, et al.
British Journal of Cancer|March 4, 1998
Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activityC Vizler, A Rosato, F Calderazzo, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damageN Bercovici, A Heurtier, C Vizler, et al.
British Journal of Cancer|March 31, 1999
Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastasesL Quintieri, A Rosato, N Amboldi, et al.
European Journal of Immunology|November 1, 1993
Autoimmunity, hyporeactivity to T cell mitogens and lymphoproliferative disorders following neonatal induction of transplantation tolerance in miceT Jánossy, L Baranyi, A C Knulst, et al.
Transplantation Proceedings|June 1, 1994
Long-term survival and use of human skin xenografts in immunosuppressed miceT Jánossy, C Vizler, J Krizsa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 22, 2000
Relative diabetogenic properties of islet-specific Tc1 and Tc2 cells in immunocompetent hostsC Vizler, N Bercovici, A Heurtier, et al.
Acta Chirurgica Hungarica|January 1, 1997
Impaired T cell functions preceding lymphoproliferative disorders in mice neonatally tolerized to transplantation antigensT Jánossy, C Vizler, I Ocsovszki, et al.
British Journal of Cancer|March 4, 1998
Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activityC Vizler, A Rosato, F Calderazzo, et al.
Pageof 2